Melatonin Supplements
Melatonin Supplements market is segmented by region (country), players, by Type and by Applicatio ... Read More
1 Study Coverage 1.1 Sleeping Pills (Prescription Drugs) Product Introduction 1.2 Global Sleeping Pills (Prescription Drugs) Outlook 2017 VS 2022 VS 2028 1.2.1 Global Sleeping Pills (Prescription Drugs) Sales in US$ Million for the Year 2017-2028 1.2.2 Global Sleeping Pills (Prescription Drugs) Sales in Volume for the Year 2017-2028 1.3 United States Sleeping Pills (Prescription Drugs) Outlook 2017 VS 2022 VS 2028 1.3.1 United States Sleeping Pills (Prescription Drugs) Sales in US$ Million for the Year 2017-2028 1.3.2 United States Sleeping Pills (Prescription Drugs) Sales in Volume for the Year 2017-2028 1.4 Sleeping Pills (Prescription Drugs) Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Sleeping Pills (Prescription Drugs) in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Sleeping Pills (Prescription Drugs) Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Sleeping Pills (Prescription Drugs) Market Dynamics 1.5.1 Sleeping Pills (Prescription Drugs) Industry Trends 1.5.2 Sleeping Pills (Prescription Drugs) Market Drivers 1.5.3 Sleeping Pills (Prescription Drugs) Market Challenges 1.5.4 Sleeping Pills (Prescription Drugs) Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Sleeping Pills (Prescription Drugs) Market Segment by Type 2.1.1 Zolpidem 2.1.2 Eszopiclone (Lunesta) 2.1.3 Ramelteon (Rozerem) 2.1.4 Ativan (lorazepam) 2.1.5 Adapin (doxepin) 2.2 Global Sleeping Pills (Prescription Drugs) Market Size by Type 2.2.1 Global Sleeping Pills (Prescription Drugs) Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Sleeping Pills (Prescription Drugs) Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Sleeping Pills (Prescription Drugs) Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Sleeping Pills (Prescription Drugs) Market Size by Type 2.3.1 United States Sleeping Pills (Prescription Drugs) Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Sleeping Pills (Prescription Drugs) Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Sleeping Pills (Prescription Drugs) Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Sleeping Pills (Prescription Drugs) Market Segment by Application 3.1.1 Hospital Pharmacy 3.1.2 Retail Pharmacy 3.2 Global Sleeping Pills (Prescription Drugs) Market Size by Application 3.2.1 Global Sleeping Pills (Prescription Drugs) Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Sleeping Pills (Prescription Drugs) Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Sleeping Pills (Prescription Drugs) Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Sleeping Pills (Prescription Drugs) Market Size by Application 3.3.1 United States Sleeping Pills (Prescription Drugs) Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Sleeping Pills (Prescription Drugs) Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Sleeping Pills (Prescription Drugs) Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Sleeping Pills (Prescription Drugs) Competitor Landscape by Company 4.1 Global Sleeping Pills (Prescription Drugs) Market Size by Company 4.1.1 Top Global Sleeping Pills (Prescription Drugs) Manufacturers Ranked by Revenue (2021) 4.1.2 Global Sleeping Pills (Prescription Drugs) Revenue by Manufacturer (2017-2022) 4.1.3 Global Sleeping Pills (Prescription Drugs) Sales by Manufacturer (2017-2022) 4.1.4 Global Sleeping Pills (Prescription Drugs) Price by Manufacturer (2017-2022) 4.2 Global Sleeping Pills (Prescription Drugs) Concentration Ratio (CR) 4.2.1 Sleeping Pills (Prescription Drugs) Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Sleeping Pills (Prescription Drugs) in 2021 4.2.3 Global Sleeping Pills (Prescription Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Sleeping Pills (Prescription Drugs) Manufacturing Base Distribution, Product Type 4.3.1 Global Sleeping Pills (Prescription Drugs) Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Sleeping Pills (Prescription Drugs) Product Type 4.3.3 Date of International Manufacturers Enter into Sleeping Pills (Prescription Drugs) Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Sleeping Pills (Prescription Drugs) Market Size by Company 4.5.1 Top Sleeping Pills (Prescription Drugs) Players in United States, Ranked by Revenue (2021) 4.5.2 United States Sleeping Pills (Prescription Drugs) Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Sleeping Pills (Prescription Drugs) Sales by Players (2020, 2021 & 2022) 5 Global Sleeping Pills (Prescription Drugs) Market Size by Region 5.1 Global Sleeping Pills (Prescription Drugs) Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Sleeping Pills (Prescription Drugs) Market Size in Volume by Region (2017-2028) 5.2.1 Global Sleeping Pills (Prescription Drugs) Sales in Volume by Region: 2017-2022 5.2.2 Global Sleeping Pills (Prescription Drugs) Sales in Volume Forecast by Region (2023-2028) 5.3 Global Sleeping Pills (Prescription Drugs) Market Size in Value by Region (2017-2028) 5.3.1 Global Sleeping Pills (Prescription Drugs) Sales in Value by Region: 2017-2022 5.3.2 Global Sleeping Pills (Prescription Drugs) Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Sleeping Pills (Prescription Drugs) Market Size YoY Growth 2017-2028 6.1.2 North America Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Sleeping Pills (Prescription Drugs) Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Sleeping Pills (Prescription Drugs) Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Sleeping Pills (Prescription Drugs) Market Size YoY Growth 2017-2028 6.3.2 Europe Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Sleeping Pills (Prescription Drugs) Market Size YoY Growth 2017-2028 6.4.2 Latin America Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Sanofi 7.1.1 Sanofi Corporation Information 7.1.2 Sanofi Description and Business Overview 7.1.3 Sanofi Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Sanofi Sleeping Pills (Prescription Drugs) Products Offered 7.1.5 Sanofi Recent Development 7.2 Abbott Laboratories 7.2.1 Abbott Laboratories Corporation Information 7.2.2 Abbott Laboratories Description and Business Overview 7.2.3 Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Abbott Laboratories Sleeping Pills (Prescription Drugs) Products Offered 7.2.5 Abbott Laboratories Recent Development 7.3 Takeda Pharmaceutical 7.3.1 Takeda Pharmaceutical Corporation Information 7.3.2 Takeda Pharmaceutical Description and Business Overview 7.3.3 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Products Offered 7.3.5 Takeda Pharmaceutical Recent Development 7.4 Apotex 7.4.1 Apotex Corporation Information 7.4.2 Apotex Description and Business Overview 7.4.3 Apotex Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Apotex Sleeping Pills (Prescription Drugs) Products Offered 7.4.5 Apotex Recent Development 7.5 Aurobindo Pharma 7.5.1 Aurobindo Pharma Corporation Information 7.5.2 Aurobindo Pharma Description and Business Overview 7.5.3 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Products Offered 7.5.5 Aurobindo Pharma Recent Development 7.6 Actellon Pharmaceuticals 7.6.1 Actellon Pharmaceuticals Corporation Information 7.6.2 Actellon Pharmaceuticals Description and Business Overview 7.6.3 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Products Offered 7.6.5 Actellon Pharmaceuticals Recent Development 7.7 Allegiant Health 7.7.1 Allegiant Health Corporation Information 7.7.2 Allegiant Health Description and Business Overview 7.7.3 Allegiant Health Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Allegiant Health Sleeping Pills (Prescription Drugs) Products Offered 7.7.5 Allegiant Health Recent Development 7.8 Cayman Chemical 7.8.1 Cayman Chemical Corporation Information 7.8.2 Cayman Chemical Description and Business Overview 7.8.3 Cayman Chemical Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Cayman Chemical Sleeping Pills (Prescription Drugs) Products Offered 7.8.5 Cayman Chemical Recent Development 7.9 Ambitropin 7.9.1 Ambitropin Corporation Information 7.9.2 Ambitropin Description and Business Overview 7.9.3 Ambitropin Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Ambitropin Sleeping Pills (Prescription Drugs) Products Offered 7.9.5 Ambitropin Recent Development 7.10 Hayao 7.10.1 Hayao Corporation Information 7.10.2 Hayao Description and Business Overview 7.10.3 Hayao Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Hayao Sleeping Pills (Prescription Drugs) Products Offered 7.10.5 Hayao Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Sleeping Pills (Prescription Drugs) Industry Chain Analysis 8.2 Sleeping Pills (Prescription Drugs) Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Sleeping Pills (Prescription Drugs) Distributors 8.3 Sleeping Pills (Prescription Drugs) Production Mode & Process 8.4 Sleeping Pills (Prescription Drugs) Sales and Marketing 8.4.1 Sleeping Pills (Prescription Drugs) Sales Channels 8.4.2 Sleeping Pills (Prescription Drugs) Distributors 8.5 Sleeping Pills (Prescription Drugs) Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
List of Tables Table 1. Sleeping Pills (Prescription Drugs) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Sleeping Pills (Prescription Drugs) Market Trends Table 3. Sleeping Pills (Prescription Drugs) Market Drivers Table 4. Sleeping Pills (Prescription Drugs) Market Challenges Table 5. Sleeping Pills (Prescription Drugs) Market Restraints Table 6. Global Sleeping Pills (Prescription Drugs) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Sleeping Pills (Prescription Drugs) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Sleeping Pills (Prescription Drugs) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Sleeping Pills (Prescription Drugs) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Sleeping Pills (Prescription Drugs) Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Sleeping Pills (Prescription Drugs) Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Sleeping Pills (Prescription Drugs) Revenue Share by Manufacturer, 2017-2022 Table 13. Global Sleeping Pills (Prescription Drugs) Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Sleeping Pills (Prescription Drugs) Sales Share by Manufacturer, 2017-2022 Table 15. Global Sleeping Pills (Prescription Drugs) Price by Manufacturer (2017-2022) & (USD/Unit) Table 16. Global Sleeping Pills (Prescription Drugs) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Sleeping Pills (Prescription Drugs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleeping Pills (Prescription Drugs) as of 2021) Table 18. Top Players of Sleeping Pills (Prescription Drugs) in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Sleeping Pills (Prescription Drugs) Product Type Table 20. Date of International Manufacturers Enter into Sleeping Pills (Prescription Drugs) Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Sleeping Pills (Prescription Drugs) Players in United States Market, Ranking by Revenue (2021) Table 23. United States Sleeping Pills (Prescription Drugs) Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Sleeping Pills (Prescription Drugs) Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Sleeping Pills (Prescription Drugs) Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Sleeping Pills (Prescription Drugs) Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Sleeping Pills (Prescription Drugs) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Sleeping Pills (Prescription Drugs) Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Sleeping Pills (Prescription Drugs) Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Sleeping Pills (Prescription Drugs) Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Sleeping Pills (Prescription Drugs) Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Sleeping Pills (Prescription Drugs) Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Sleeping Pills (Prescription Drugs) Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Sleeping Pills (Prescription Drugs) Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Sleeping Pills (Prescription Drugs) Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Sleeping Pills (Prescription Drugs) Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Sleeping Pills (Prescription Drugs) Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Sleeping Pills (Prescription Drugs) Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Sleeping Pills (Prescription Drugs) Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Sanofi Corporation Information Table 43. Sanofi Description and Business Overview Table 44. Sanofi Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 45. Sanofi Sleeping Pills (Prescription Drugs) Product Table 46. Sanofi Recent Development Table 47. Abbott Laboratories Corporation Information Table 48. Abbott Laboratories Description and Business Overview Table 49. Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 50. Abbott Laboratories Product Table 51. Abbott Laboratories Recent Development Table 52. Takeda Pharmaceutical Corporation Information Table 53. Takeda Pharmaceutical Description and Business Overview Table 54. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 55. Takeda Pharmaceutical Product Table 56. Takeda Pharmaceutical Recent Development Table 57. Apotex Corporation Information Table 58. Apotex Description and Business Overview Table 59. Apotex Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 60. Apotex Product Table 61. Apotex Recent Development Table 62. Aurobindo Pharma Corporation Information Table 63. Aurobindo Pharma Description and Business Overview Table 64. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Aurobindo Pharma Product Table 66. Aurobindo Pharma Recent Development Table 67. Actellon Pharmaceuticals Corporation Information Table 68. Actellon Pharmaceuticals Description and Business Overview Table 69. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 70. Actellon Pharmaceuticals Product Table 71. Actellon Pharmaceuticals Recent Development Table 72. Allegiant Health Corporation Information Table 73. Allegiant Health Description and Business Overview Table 74. Allegiant Health Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 75. Allegiant Health Product Table 76. Allegiant Health Recent Development Table 77. Cayman Chemical Corporation Information Table 78. Cayman Chemical Description and Business Overview Table 79. Cayman Chemical Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 80. Cayman Chemical Product Table 81. Cayman Chemical Recent Development Table 82. Ambitropin Corporation Information Table 83. Ambitropin Description and Business Overview Table 84. Ambitropin Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 85. Ambitropin Product Table 86. Ambitropin Recent Development Table 87. Hayao Corporation Information Table 88. Hayao Description and Business Overview Table 89. Hayao Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 90. Hayao Product Table 91. Hayao Recent Development Table 92. Key Raw Materials Lists Table 93. Raw Materials Key Suppliers Lists Table 94. Sleeping Pills (Prescription Drugs) Customers List Table 95. Sleeping Pills (Prescription Drugs) Distributors List Table 96. Research Programs/Design for This Report Table 97. Key Data Information from Secondary Sources Table 98. Key Data Information from Primary Sources List of Figures Figure 1. Sleeping Pills (Prescription Drugs) Product Picture Figure 2. Global Sleeping Pills (Prescription Drugs) Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Sleeping Pills (Prescription Drugs) Market Size 2017-2028 (US$ Million) Figure 4. Global Sleeping Pills (Prescription Drugs) Sales 2017-2028 (K Units) Figure 5. United States Sleeping Pills (Prescription Drugs) Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Sleeping Pills (Prescription Drugs) Market Size 2017-2028 (US$ Million) Figure 7. United States Sleeping Pills (Prescription Drugs) Sales 2017-2028 (K Units) Figure 8. United States Sleeping Pills (Prescription Drugs) Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Sleeping Pills (Prescription Drugs) Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Sleeping Pills (Prescription Drugs) Report Years Considered Figure 11. Product Picture of Zolpidem Figure 12. Product Picture of Eszopiclone (Lunesta) Figure 13. Product Picture of Ramelteon (Rozerem) Figure 14. Product Picture of Ativan (lorazepam) Figure 15. Product Picture of Adapin (doxepin) Figure 16. Global Sleeping Pills (Prescription Drugs) Market Share by Type in 2022 & 2028 Figure 17. Global Sleeping Pills (Prescription Drugs) Sales in Value by Type (2017-2028) & (US$ Million) Figure 18. Global Sleeping Pills (Prescription Drugs) Sales Market Share in Value by Type (2017-2028) Figure 19. Global Sleeping Pills (Prescription Drugs) Sales by Type (2017-2028) & (K Units) Figure 20. Global Sleeping Pills (Prescription Drugs) Sales Market Share in Volume by Type (2017-2028) Figure 21. Global Sleeping Pills (Prescription Drugs) Price by Type (2017-2028) & (USD/Unit) Figure 22. United States Sleeping Pills (Prescription Drugs) Market Share by Type in 2022 & 2028 Figure 23. United States Sleeping Pills (Prescription Drugs) Sales in Value by Type (2017-2028) & (US$ Million) Figure 24. United States Sleeping Pills (Prescription Drugs) Sales Market Share in Value by Type (2017-2028) Figure 25. United States Sleeping Pills (Prescription Drugs) Sales by Type (2017-2028) & (K Units) Figure 26. United States Sleeping Pills (Prescription Drugs) Sales Market Share in Volume by Type (2017-2028) Figure 27. United States Sleeping Pills (Prescription Drugs) Price by Type (2017-2028) & (USD/Unit) Figure 28. Product Picture of Hospital Pharmacy Figure 29. Product Picture of Retail Pharmacy Figure 30. Global Sleeping Pills (Prescription Drugs) Market Share by Application in 2022 & 2028 Figure 31. Global Sleeping Pills (Prescription Drugs) Sales in Value by Application (2017-2028) & (US$ Million) Figure 32. Global Sleeping Pills (Prescription Drugs) Sales Market Share in Value by Application (2017-2028) Figure 33. Global Sleeping Pills (Prescription Drugs) Sales by Application (2017-2028) & (K Units) Figure 34. Global Sleeping Pills (Prescription Drugs) Sales Market Share in Volume by Application (2017-2028) Figure 35. Global Sleeping Pills (Prescription Drugs) Price by Application (2017-2028) & (USD/Unit) Figure 36. United States Sleeping Pills (Prescription Drugs) Market Share by Application in 2022 & 2028 Figure 37. United States Sleeping Pills (Prescription Drugs) Sales in Value by Application (2017-2028) & (US$ Million) Figure 38. United States Sleeping Pills (Prescription Drugs) Sales Market Share in Value by Application (2017-2028) Figure 39. United States Sleeping Pills (Prescription Drugs) Sales by Application (2017-2028) & (K Units) Figure 40. United States Sleeping Pills (Prescription Drugs) Sales Market Share in Volume by Application (2017-2028) Figure 41. United States Sleeping Pills (Prescription Drugs) Price by Application (2017-2028) & (USD/Unit) Figure 42. North America Sleeping Pills (Prescription Drugs) Sales in Volume Growth Rate 2017-2028 (K Units) Figure 43. North America Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 44. U.S. Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Canada Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 46. Europe Sleeping Pills (Prescription Drugs) Sales in Volume Growth Rate 2017-2028 (K Units) Figure 47. Europe Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 48. Germany Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. France Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. U.K. Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Italy Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Russia Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 53. Asia-Pacific Sleeping Pills (Prescription Drugs) Sales in Volume Growth Rate 2017-2028 (K Units) Figure 54. Asia-Pacific Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 55. China Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. Japan Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. South Korea Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. India Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Australia Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Taiwan Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Indonesia Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Thailand Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Malaysia Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Philippines Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Latin America Sleeping Pills (Prescription Drugs) Sales in Volume Growth Rate 2017-2028 (K Units) Figure 66. Latin America Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 67. Mexico Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Brazil Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Argentina Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 70. Middle East & Africa Sleeping Pills (Prescription Drugs) Sales in Volume Growth Rate 2017-2028 (K Units) Figure 71. Middle East & Africa Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 72. Turkey Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. Saudi Arabia Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. U.A.E Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 75. Sleeping Pills (Prescription Drugs) Value Chain Figure 76. Sleeping Pills (Prescription Drugs) Production Process Figure 77. Channels of Distribution Figure 78. Distributors Profiles Figure 79. Bottom-up and Top-down Approaches for This Report Figure 80. Data Triangulation Figure 81. Key Executives Interviewed
Sanofi Abbott Laboratories Takeda Pharmaceutical Apotex Aurobindo Pharma Actellon Pharmaceuticals Allegiant Health Cayman Chemical Ambitropin Hayao
Melatonin Supplements market is segmented by region (country), players, by Type and by Applicatio ... Read More
Amoxicillin Sodium market is segmented by region (country), players, by Type and by Application. ... Read More
Automated Ultrasonic Atomizers market is segmented by region (country), players, by Type and by A ... Read More
Clavulanate Potassium market is segmented by region (country), players, by Type and by Applicatio ... Read More